The digital journey: 25 years of digital development in electrophysiology from an Europace perspective
- PMID: 37622574
- PMCID: PMC10450797
- DOI: 10.1093/europace/euad176
The digital journey: 25 years of digital development in electrophysiology from an Europace perspective
Abstract
Aims: Over the past 25 years there has been a substantial development in the field of digital electrophysiology (EP) and in parallel a substantial increase in publications on digital cardiology.In this celebratory paper, we provide an overview of the digital field by highlighting publications from the field focusing on the EP Europace journal.
Results: In this journey across the past quarter of a century we follow the development of digital tools commonly used in the clinic spanning from the initiation of digital clinics through the early days of telemonitoring, to wearables, mobile applications, and the use of fully virtual clinics. We then provide a chronicle of the field of artificial intelligence, a regulatory perspective, and at the end of our journey provide a future outlook for digital EP.
Conclusion: Over the past 25 years Europace has published a substantial number of papers on digital EP, with a marked expansion in digital publications in recent years.
Keywords: Artificial intelligence; Digital; Telemonitoring.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: ES declares lecture fees from Bayer, Bristol-Myers Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme PS is supported by an Investigator Grant from the National Health and Medical Research Council of Australia. Conflict of Interest Disclosures: PS reports having served on the advisory board of Boston Scientific, CathRx, Medtronic, Abbott Medical and Pacemate. PS reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Medtronic, Boston-Scientific, and Abbott Medical, Pacemate and CathRx. PS reports that the University of Adelaide has received on his behalf research funding from Medtronic, Abbott Medical, Boston-Scientific, Pacemate, Becton Dickinson and Microport. JH reports advisory board: iRhythm Technologies Consultant: Abbott Medical Lectureship fees: Medtronic & 91 Life/ScottCare EC, LD, FER.
Figures
References
-
- Heidbüchel H, Lioen P, Foulon S, Huybrechts W, Ector J, Willems Ret al. . Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 2008;10:351–7. - PubMed
-
- Neuzil P, Taborsky M, Holy F, Wallbrueck K. Early automatic remote detection of combined lead insulation defect and ICD damage. Europace 2008;10:556–7. - PubMed
-
- Nielsen JC, Kottkamp H, Zabel M, Aliot E, Kreutzer U, Bauer Aet al. . Automatic home monitoring of implantable cardioverter defibrillators. Europace 2008;10:729–35. - PubMed
-
- Perings C, Klein G, Toft E, Moro C, Klug D, Böcker Det al. . The RIONI study rationale and design: validation of the first stored electrograms transmitted via home monitoring in patients with implantable defibrillators. Europace 2006;8:288–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous